Injection Adrenaline 1 ML,Injection Atropine 1 ML,Injection Avil 2ML,Injection PCM 1GM,Injection Ne
History Division
ALMORA, UTTARAKHAND
Bid Publish Date
14-Nov-2024, 8:46 pm
Bid End Date
05-Dec-2024, 9:00 pm
Progress
RAQuantity
8825
Category
Acalabrutinib 100 Mg tablet
Bid Type
Two Packet Bid
Employees State Insurance Corporation (esic) has released a public tender for Acalabrutinib 100 Mg tablet, Botrtezomib 2 mg injection, Botulinum Toxin 200 IU injection, Cetuximab 100 mg injection, Cetuximab 500 mg injection, Cyclophosphamide 500 mg Injection, Cyclophosphamide 1 gm Injection, Doxorubicin 50 mg injection, Eltrombopag 25 mg tablet, Eltrombopag 50 mg tablet, Enzalutamide 80 mg tablet, Factor VIII 250 IU injection, Factor VIII 1000 IU injection, Lenalidomide 10 mg Tablet, Lenalidomide 25mg tablet, Nilotinib 150 mg tablet, Ramucirumab 100 mg injection, Rituximab 100 mg injection, Rituximab 500 mg injection, Romiplostim 500 mg injection, Vincristine 1 mg injection, Oxaliplatin 50 mg Injection, Oxaliplatin 100 mg Injection, Inj. Surfactant 4mg, Injection Caffeine 20mg per vial, Sofosbuvir 400mg Velpatasvir 100mg tablets, Tenofovir disoproxel fumarate 300mg, Ropivacaine 2mg, Rocuronium 100mg, Sevoflurane inhaler 250ml, injection Hyaluronic acid 20mg per vial, Betadine solution 10 percent 500 ml. Quantity: 8825. Submission Deadline: 05-12-2024 21: 00: 00. Download documents and apply online.
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
History Division
ALMORA, UTTARAKHAND
Hscc India Ltd
RAEBARELI, UTTAR PRADESH
Indian Army
Indian Army
POONCH, JAMMU & KASHMIR
Indian Army
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Acalabrutinib 100 Mg tablet | Tablet | 250 | nos | dr.apurbak | 365 |
| 2 | Botrtezomib 2 mg injection | injection | 25 | nos | dr.apurbak | 365 |
| 3 | Botulinum Toxin 200 IU injection | injection | 50 | nos | dr.apurbak | 365 |
| 4 | Cetuximab 100 mg injection | injection | 50 | nos | dr.apurbak | 365 |
| 5 | Cetuximab 500 mg injection | injection | 50 | nos | dr.apurbak | 365 |
| 6 | Cyclophosphamide 500 mg Injection | injection | 50 | nos | dr.apurbak | 365 |
| 7 | Cyclophosphamide 1 gm Injection | injection | 50 | nos | dr.apurbak | 365 |
| 8 | Doxorubicin 50 mg injection | injection | 10 | nos | dr.apurbak | 365 |
| 9 | Eltrombopag 25 mg tablet | Tablet | 20 | nos | dr.apurbak | 365 |
| 10 | Eltrombopag 50 mg tablet | Tablet | 150 | nos | dr.apurbak | 365 |
| 11 | Enzalutamide 80 mg tablet | Tablet | 50 | nos | dr.apurbak | 365 |
| 12 | Factor VIII 250 IU injection | injection | 50 | nos | dr.apurbak | 365 |
| 13 | Factor VIII 1000 IU injection | injection | 10 | nos | dr.apurbak | 365 |
| 14 | Lenalidomide 10 mg Tablet | Tablet | 50 | nos | dr.apurbak | 365 |
| 15 | Lenalidomide 25mg tablet | Tablet | 50 | nos | dr.apurbak | 365 |
| 16 | Nilotinib 150 mg tablet | Tablet | 150 | nos | dr.apurbak | 365 |
| 17 | Ramucirumab 100 mg injection | injection | 10 | nos | dr.apurbak | 365 |
| 18 | Rituximab 100 mg injection | injection | 50 | nos | dr.apurbak | 365 |
| 19 | Rituximab 500 mg injection | injection | 50 | nos | dr.apurbak | 365 |
| 20 | Romiplostim 500 mg injection | injection | 200 | nos | dr.apurbak | 365 |
| 21 | Vincristine 1 mg injection | injection | 50 | nos | dr.apurbak | 365 |
| 22 | Oxaliplatin 50 mg Injection | injection | 100 | nos | dr.apurbak | 365 |
| 23 | Oxaliplatin 100 mg Injection | injection | 100 | nos | dr.apurbak | 365 |
| 24 | Inj. Surfactant 4mg | injection | 20 | nos | dr.apurbak | 365 |
| 25 | Injection Caffeine 20mg per vial | injection | 30 | nos | dr.apurbak | 365 |
| 26 | Sofosbuvir 400mg Velpatasvir 100mg tablets | Tablet | 3,000 | nos | dr.apurbak | 365 |
| 27 | Tenofovir disoproxel fumarate 300mg | Tablet | 2,000 | nos | dr.apurbak | 365 |
| 28 | Ropivacaine 2mg | injection | 500 | nos | dr.apurbak | 365 |
| 29 | Rocuronium 100mg | injection | 500 | nos | dr.apurbak | 365 |
| 30 | Sevoflurane inhaler 250ml | inhaler | 500 | nos | dr.apurbak | 365 |
| 31 | injection Hyaluronic acid 20mg per vial | Injection | 50 | nos | dr.apurbak | 365 |
| 32 | Betadine solution 10 percent 500 ml | Solution | 600 | bottle | dr.apurbak | 365 |
Discover companies most likely to bid on this tender
Experience Criteria
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Start
19-Mar-2025, 11:00 am
End
20-Mar-2025, 11:00 am
Duration: 24 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
The eligibility requirements include being a registered entity, demonstrating a minimum average annual turnover of 70 Lakhs, having at least three years of experience in supplying pharmaceutical products, and producing relevant certificates, such as the OEM authorization. MSEs and startups may seek exemptions from experience requirements upon providing supporting documents.
Bidders must provide several required certificates, including OEM Authorization, Compliance of BoQ specifications, and documentation stating prior experiences. If seeking exemptions from experience or turnover criteria, corresponding supporting documents must also be submitted for evaluation.
The registration process typically involves creating an account on the designated procurement platform and submitting necessary documentation as outlined in the tender notice. This includes financial statements and certificates proving eligibility.
Typically, the accepted document formats include PDF, Word documents, and scanned versions of physical copies. Specific file formats may be specified in the main tender document.
The technical specifications are detailed in the Bill of Quantities (BoQ) accompanying the tender. Bidders must ensure their products meet or exceed these standards to be considered compliant.
Bidders must adhere to the quality standards as stipulated in the BoQ. This includes meeting pharmaceutical safety regulations and maintaining adequate supply chain practices.
The compliance requirements include adherence to pharmaceutical regulations, possessing necessary licenses for the supply of medicines, and fulfilling all document provisions made in the tender.
While specific testing criteria may not be detailed in the tender, general compliance with the applicable health and safety standards mandated by regulatory authorities must be maintained.
The EMD details will be specified in the tender documentation, including the amount, submission method, and due date. Bidders should ensure timely compliance to participate.
The performance security requirements will involve a stipulated percentage of the total bid amount, which must be submitted upon contract award. This is to ensure compliance with the agreement terms.
The payment terms will be outlined in the tender documentation. They generally pertain to milestones of delivery, satisfactory completion of contract requirements, and timelines for invoice payments.
Price evaluation considerations will focus on the financial bids of technically qualified bidders and compare prices item-wise, with an emphasis on the lowest priced options that meet the technical requirements.
Submission methods typically involve electronic uploads via the procurement portal. Bidders are encouraged to ensure that all required documentation is submitted before the deadline.
While specific key timelines and deadlines may vary, bidders should monitor the tender documents for any announced critical dates related to bid submission, opening, and evaluation.
The evaluation and selection process involves an initial technical assessment followed by a financial evaluation. Bids will be ranked based on compliance and cost, focusing on technico-commercial evaluations for selection.
Notifications of results are usually communicated via the procurement portal or through registered communication means indicated during the tender submission. Bidders should ensure their contact information is accurate.
MSEs benefit from exemptions regarding experience and turnover requirements. These provisions aim to encourage broad participation and support smaller businesses in the tendering process.
Startups can also avail exemptions from the experience criteria, provided they can demonstrate eligibility through adequate documentation and necessary compliance with the tender requirements.
Compliance with 'Make in India' policies is encouraged within this tender framework; bidders are advised to source and produce goods locally where possible while adhering to procurement rules and local content specifications.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS